NASDAQ · Biotechnology

HYFT (HYFT) Stock

$1.29 -4.44% NASDAQ: HYFT Healthcare

Valuation

MetricValue
Price$1.29
Market Cap$60.61M
P/E Ratio-1.77
P/B Ratio3.09
P/S Ratio5.61
EPS (TTM)$-0.90
52-Week High$3.25
52-Week Low$0.82
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-125.00%
ROA-68.18%
ROCE-52.17%
Gross Margin-54.17%
Operating Margin-50.00%
Net Margin-66.77%
Debt/Equity0.24
Current Ratio2.11

Annual Financials (USD)

Metric20212022202320242025
Revenue$18.0M$20.0M$21.0M$25.0M$24.0M
Operating Profit$-4.0M$-17.0M$-29.0M$-14.0M$-12.0M
Net Profit$-7.0M$-17.0M$-27.0M$-26.0M$-30.0M
EPS$-0.45$-0.87$-1.07$-1.03$-0.90
Op Margin-21.9%-86.5%-138.2%-57.5%-50.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$67.0M$93.0M$78.0M$60.0M$44.0M
Total Liabilities$10.0M$18.0M$20.0M$26.0M$21.0M
Cash$42.0M$30.0M$8.0M$3.0M$11.0M
Borrowings$3.0M$3.0M$7.0M$14.0M$13.0M

Latest News

As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22 CNW Group · Jul 15, 2026 MindWalk Holdings Files $250 Million Shelf Registration MT Newswires · Jul 13, 2026 MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2026 on July 22, 2026 Business Wire · Jul 13, 2026 MindWalk Holdings Corp. (NASDAQ: HYFT) Added to the Russell 3000E Index, Expanding Institutional Investment Opportunity Business Wire · Jul 6, 2026 MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery Business Wire · Jul 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-10.0M$-20.0M$-4.0M$-6.0M
Investing Cash Flow$-4.0M$-6.0M$-3.0M$-3.0M$-2.0M
Financing Cash Flow$0$0$0$1.0M$0
Net Cash Flow$39.0M$-12.0M$-22.0M$-5.0M$7.0M
Free Cash Flow$-2.0M$-11.0M$-21.0M$-6.0M$-7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-11.63%
Quick Ratio3.64
Interest Coverage—
Return 1Y-17.58%
Return 3Y-46.81%
Return 5Y-72.38%

Ownership

Insiders Held9.02%
Institutions Held9.99%
Institutions Float Held10.98%
Institutional HolderSharesReport Date
Ingalls & Snyder LLC2,907,0402026-03-31
Susquehanna International Group, LLP534,0162026-03-31
Renaissance Technologies, LLC232,4802026-03-31
Xtx Topco Ltd172,5472026-03-31
Citadel Advisors Llc147,9072026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALXO $1.95 -2.26% -1.04 $261.72M 0.00%
ATYR $0.49 +1.19% -0.72 $47.62M 0.00%
BYSIBeyondSpring Inc. $1.17 +4.46% -5.90 $48.11M 0.00%
CAMP $3.47 +6.12% -1.70 $73.70M 0.00%
CLNNClene Inc. $5.29 -1.86% -1.66 $54.53M 0.00%

About HYFT

HYFT is led by CEO Jennifer Lynne Bath, publicly traded since 2002.

HYFT stock trades at $1.29 with a market capitalization of $60.61M. The stock is valued at a price-to-earnings (P/E) ratio of -1.77, price-to-book of 3.09, price-to-sales of 5.61. Over the past 52 weeks the stock has ranged between $0.82 and $3.25, and currently trades 60.3% below its 52-week high.

On profitability, HYFT generates a return on equity (ROE) of -125.00%, return on capital employed of -52.17%, an operating margin of -50.00%, a net profit margin of -66.77%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides